ANDROGEN DEPRIVATION THERAPY
Clinical trials for ANDROGEN DEPRIVATION THERAPY explained in plain language.
Never miss a new study
Get alerted when new ANDROGEN DEPRIVATION THERAPY trials appear
Sign up with your email to follow new studies for ANDROGEN DEPRIVATION THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can home workouts protect hearts of black prostate cancer patients?
Disease control Recruiting nowThis study is testing whether a 16-week home exercise program can improve heart health in Black men with prostate cancer who are receiving hormone therapy. Researchers will compare a group doing supervised virtual workouts with a group maintaining their usual activity. The goal i…
Matched conditions: ANDROGEN DEPRIVATION THERAPY
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
New drug duo aims to tame tough prostate cancer
Disease control Recruiting nowThis early-stage trial is testing if combining two medications, relugolix and enzalutamide, can better control high-risk, locally advanced prostate cancer. About 46 men will take these drugs before and after their standard treatment, which is either surgery or radiation therapy. …
Matched conditions: ANDROGEN DEPRIVATION THERAPY
Phase: PHASE1 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
New hope for men suffering from cancer treatment side effects
Symptom relief Recruiting nowThis study is testing a drug called fezolinetant to see if it can reduce hot flashes in men receiving hormone-blocking therapy for prostate cancer. Researchers want to find a non-hormonal way to manage this common and bothersome side effect that affects quality of life. The study…
Matched conditions: ANDROGEN DEPRIVATION THERAPY
Phase: PHASE2 • Sponsor: University of Vermont • Aim: Symptom relief
Last updated Mar 27, 2026 12:39 UTC
-
New hope for men suffering debilitating hot flashes from cancer treatment
Symptom relief Recruiting nowThis study is testing whether a medication called fezolinetant can safely reduce the frequency and severity of hot flashes in men with prostate cancer who are undergoing hormone-blocking therapy. Researchers will compare the drug to a placebo in 60 participants over 4 weeks to se…
Matched conditions: ANDROGEN DEPRIVATION THERAPY
Phase: PHASE2 • Sponsor: Shehzad Basaria, M.D. • Aim: Symptom relief
Last updated Mar 27, 2026 12:38 UTC
-
Needles vs. night sweats: ancient practice tested for modern cancer side effect
Symptom relief Recruiting nowThis small pilot study is testing whether acupuncture is a practical and helpful way to reduce hot flashes in men receiving hormone therapy for prostate cancer. 24 men will be randomly assigned to start acupuncture right away or after a waiting period, while all receive standard …
Matched conditions: ANDROGEN DEPRIVATION THERAPY
Phase: NA • Sponsor: Inova Health Care Services • Aim: Symptom relief
Last updated Feb 27, 2026 15:19 UTC